Endoscopic Tri-Modal Imaging (ETMI) for the detection of early neoplasia in patients with Barrett*s esophagus (BE) in tertiary referral centers; a randomized cross-over multi-center study.

Endoscopic Tri-Modal Imaging (ETMI) for the detection of early neoplasia in patients with Barrett*s esophagus (BE) in tertiary referral centers; a randomized cross-over multi-center study. - ETMIcross

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30430

Enrollment

Registered

2007-01-23

Start date

2006-01-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett's esophagus esophageal cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >18 years Prior diagnosis of Barrett's esophagus Minimum Barrett's length of C>2M>2 or C4 according to the Prague C&M classification Written informed consent

Exclusion criteria

Exclusion criteria: Presence of esophagitis > grade A according to the LA classification of erosive esophagitis Presence of conditions precluding histological sampling of the esophagus

Design outcomes

Primary

Measure	Time frame
Number of patients detected with dysplasia. Number of lesions detected with dysplasia.	—

Secondary

Measure	Time frame
Positive predictive value of high-resolution white light endoscopy and autofluorescence imaging. Reduction of fals-positive findingfs with narrow band imaging.	—

Countries

Netherlands

Outcome results